Michelle Polowski

Michelle leads Development Operations at Denali. In this role, Michelle manages Biomarker Operations, Clinical Operations, Clinical Outsourcing and Business Operations, and Data Management for Denali’s early- and late-stage clinical programs.

Prior to joining Denali, Michelle was Sr. Vice President of Global Development Operations at Ultragenyx. Michelle led a cross-functional group at Ultragenyx to deliver on clinical trial programs across multiple rare and ultra-rare disease programs resulting in marketing approval for three products in four indications. Before joining Ultragenyx, Michelle held various roles of increasing responsibility in Clinical Operations, Business Operations, and Quality and Compliance at Genentech, La Jolla Pharmaceutical Company, PAREXEL and Automedics.

Michelle has an MBA from Pepperdine Graziadio Business School, MS in Regulatory Affairs from San Diego State University, and a BS in Microbiology from University of California, San Diego.